Profile for Canada Patent: 3062005
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 3062005
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Aug 20, 2030 | Lnhc | ZELSUVMI | berdazimer sodium |
| ⤷ Start Trial | Sep 3, 2031 | Lnhc | ZELSUVMI | berdazimer sodium |
| ⤷ Start Trial | Aug 20, 2030 | Lnhc | ZELSUVMI | berdazimer sodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
